vs
Side-by-side financial comparison of Dole plc (DOLE) and Organon & Co. (OGN). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.5B, roughly 1.5× Organon & Co.). Dole plc runs the higher net margin — 0.2% vs -13.6%, a 13.8% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $66.5M). Over the past eight quarters, Dole plc's revenue compounded faster (3.2% CAGR vs -3.6%).
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
DOLE vs OGN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.5B |
| Net Profit | $5.1M | $-205.0M |
| Gross Margin | 6.8% | 49.2% |
| Operating Margin | 1.1% | -9.8% |
| Net Margin | 0.2% | -13.6% |
| Revenue YoY | 10.5% | -5.3% |
| Net Profit YoY | -64.6% | -288.1% |
| EPS (diluted) | $0.05 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.5B | ||
| Q3 25 | $2.3B | $1.6B | ||
| Q2 25 | $2.4B | $1.6B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.1B | $1.6B | ||
| Q1 24 | $2.1B | $1.6B |
| Q4 25 | — | $-205.0M | ||
| Q3 25 | $5.1M | $160.0M | ||
| Q2 25 | $10.0M | $145.0M | ||
| Q1 25 | $38.9M | $87.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | $14.4M | $359.0M | ||
| Q2 24 | $80.1M | $195.0M | ||
| Q1 24 | $70.1M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | 6.8% | 53.5% | ||
| Q2 25 | 9.0% | 54.8% | ||
| Q1 25 | 8.7% | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | 8.0% | 58.3% | ||
| Q2 24 | 9.4% | 58.4% | ||
| Q1 24 | 9.2% | 59.0% |
| Q4 25 | — | -9.8% | ||
| Q3 25 | 1.1% | 15.2% | ||
| Q2 25 | 4.3% | 14.4% | ||
| Q1 25 | 3.2% | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | 2.3% | 13.1% | ||
| Q2 24 | 4.0% | 14.6% | ||
| Q1 24 | 5.3% | 14.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | 0.2% | 10.0% | ||
| Q2 25 | 0.4% | 9.1% | ||
| Q1 25 | 1.9% | 5.8% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | 0.7% | 22.7% | ||
| Q2 24 | 3.8% | 12.1% | ||
| Q1 24 | 3.3% | 12.4% |
| Q4 25 | — | $-0.78 | ||
| Q3 25 | $0.05 | $0.61 | ||
| Q2 25 | $0.10 | $0.56 | ||
| Q1 25 | $0.41 | $0.33 | ||
| Q4 24 | — | $0.42 | ||
| Q3 24 | $0.15 | $1.38 | ||
| Q2 24 | $0.84 | $0.75 | ||
| Q1 24 | $0.74 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.0M | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $1.4B | $752.0M |
| Total Assets | $4.5B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | $321.0M | $672.0M | ||
| Q2 25 | $323.1M | $599.0M | ||
| Q1 25 | $261.0M | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | $266.4M | $763.0M | ||
| Q2 24 | $225.8M | $704.0M | ||
| Q1 24 | $245.5M | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | — | $752.0M | ||
| Q3 25 | $1.4B | $906.0M | ||
| Q2 25 | $1.4B | $733.0M | ||
| Q1 25 | $1.3B | $542.0M | ||
| Q4 24 | — | $472.0M | ||
| Q3 24 | $1.4B | $493.0M | ||
| Q2 24 | $1.4B | $144.0M | ||
| Q1 24 | $1.3B | $48.0M |
| Q4 25 | — | $12.9B | ||
| Q3 25 | $4.5B | $13.6B | ||
| Q2 25 | $4.7B | $13.5B | ||
| Q1 25 | $4.5B | $13.2B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | $4.5B | $12.8B | ||
| Q2 24 | $4.4B | $12.2B | ||
| Q1 24 | $4.5B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.4M | $141.0M |
| Free Cash FlowOCF − Capex | $66.5M | $96.0M |
| FCF MarginFCF / Revenue | 2.9% | 6.4% |
| Capex IntensityCapex / Revenue | 0.9% | 3.0% |
| Cash ConversionOCF / Net Profit | 17.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.7M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $141.0M | ||
| Q3 25 | $87.4M | $264.0M | ||
| Q2 25 | $18.3M | $220.0M | ||
| Q1 25 | $-78.8M | $75.0M | ||
| Q4 24 | — | $390.0M | ||
| Q3 24 | $101.0M | $141.0M | ||
| Q2 24 | $40.2M | $332.0M | ||
| Q1 24 | $-35.0M | $76.0M |
| Q4 25 | — | $96.0M | ||
| Q3 25 | $66.5M | $218.0M | ||
| Q2 25 | $-1.0M | $181.0M | ||
| Q1 25 | $-131.6M | $43.0M | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | $79.9M | $99.0M | ||
| Q2 24 | $22.8M | $300.0M | ||
| Q1 24 | $-53.2M | $30.0M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | 2.9% | 13.6% | ||
| Q2 25 | -0.0% | 11.4% | ||
| Q1 25 | -6.3% | 2.8% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | 3.9% | 6.3% | ||
| Q2 24 | 1.1% | 18.7% | ||
| Q1 24 | -2.5% | 1.8% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | 0.9% | 2.9% | ||
| Q2 25 | 0.8% | 2.4% | ||
| Q1 25 | 2.5% | 2.1% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 1.0% | 2.7% | ||
| Q2 24 | 0.8% | 2.0% | ||
| Q1 24 | 0.9% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | 17.12× | 1.65× | ||
| Q2 25 | 1.84× | 1.52× | ||
| Q1 25 | -2.02× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | 7.01× | 0.39× | ||
| Q2 24 | 0.50× | 1.70× | ||
| Q1 24 | -0.50× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
